← Leaderboards
Anne Christine Eichmann
Yale University
$13,173,934
Attributed
$18,536,176
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,536,176 · 10
By mechanism
R01$18,516,176 · 9
R13$20,000 · 1
Top collaborators
- Jean-Leon Thomas5 shared
- Martin A. Schwartz4 shared
- Michael Simons4 shared
- Akiko Iwasaki3 shared
- Helene D Benveniste2 shared
- Laura Santambrogio2 shared
Most similar at Yale University
Same institution · by research overlap
- Michael Simons$49,269,368
- Stephanie Caroline Eisenbarth$11,539,178
- Lucia Beatrice Jilaveanu$2,746,145
- Martin A. Schwartz$34,384,106
- Harriet M Kluger$18,066,555
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularPathway InteractionsMediatingBiologicalSignal TransductionCellsBlood VesselsReceptorMouse ModelNovel StrategiesNovel TherapeuticsVascular Endothelial Growth FactorsIn VivoAffectPreventResponseInflammationGeneticAngiogenesisKdr GeneBaseEndothelial CellsLoss Of FunctionEndothelium
Grant awards (35)
Endothelial protocadherins in vascular development and disease$775,720
R01 · FY2025 · HL
Flow regulation of the Alk1/Eng pathway in vascular homeostasis and disease$758,693
R01 · FY2025 · HL · contact PI
Lymphatic drainage dysfunction in chronic hypertension$747,191
R01 · FY2025 · HL
Slit2-ROBO signaling in pericytes and myeloid cells controls vascular development and ocular neovascular disease$609,439
R01 · FY2025 · HL · contact PI
Role of meningeal lymphatic vasculature in neuroimmune communication development$494,067
R01 · FY2025 · NS
2025 Angiogenesis Gordon Research Conference and Gordon Research Seminar$20,000
R13 · FY2025 · HL · contact PI
Lymphatic drainage dysfunction in chronic hypertension$772,960
R01 · FY2024 · HL
Flow regulation of the Alk1/Eng pathway in vascular homeostasis and disease$743,519
R01 · FY2024 · HL · contact PI
Slit2-ROBO signaling in pericytes and myeloid cells controls vascular development and ocular neovascular disease$589,042
R01 · FY2024 · HL · contact PI
Role of meningeal lymphatic vasculature in neuroimmune communication development$548,579
R01 · FY2024 · NS
Flow regulation of the Alk1/Eng pathway in vascular homeostasis and disease$775,568
R01 · FY2023 · HL · contact PI
Slit2-ROBO signaling in pericytes and myeloid cells controls vascular development and ocular neovascular disease$601,064
R01 · FY2023 · HL · contact PI
Role of meningeal lymphatic vasculature in neuroimmune communication development$524,089
R01 · FY2023 · NS
Dynamic control of vascular permeability in development and disease$813,824
R01 · FY2022 · HL · contact PI
Slit2-ROBO signaling in pericytes and myeloid cells controls vascular development and ocular neovascular disease$601,064
R01 · FY2022 · HL · contact PI
Novel approached to prevent diet-induced obesity via lacteal junctions$376,875
R01 · FY2022 · DK · contact PI
Dynamic control of vascular permeability in development and disease$821,781
R01 · FY2021 · HL · contact PI
Novel approached to prevent diet-induced obesity via lacteal junctions$376,875
R01 · FY2021 · DK · contact PI
Dynamic control of vascular permeability in development and disease$829,318
R01 · FY2020 · HL · contact PI
Novel approached to prevent diet-induced obesity via lacteal junctions$376,875
R01 · FY2020 · DK · contact PI
Dynamic control of vascular permeability in development and disease$836,855
R01 · FY2019 · HL · contact PI
Novel approached to prevent diet-induced obesity via lacteal junctions$376,875
R01 · FY2019 · DK · contact PI
Novel approaches to manipulate sprouting angiogenesis$374,625
R01 · FY2019 · EY · contact PI
Targeting endothelial migration to prevent neovascularization$416,250
R01 · FY2018 · HL · contact PI
Novel approaches to manipulate sprouting angiogenesis$374,625
R01 · FY2018 · EY · contact PI
Targeting endothelial migration to prevent neovascularization$416,250
R01 · FY2017 · HL · contact PI
Novel approaches to manipulate sprouting angiogenesis$374,625
R01 · FY2017 · EY · contact PI
Targeting endothelial migration to prevent neovascularization$416,250
R01 · FY2016 · HL · contact PI
Novel approaches to manipulate sprouting angiogenesis$374,625
R01 · FY2016 · EY · contact PI
Targeting endothelial migration to prevent neovascularization$416,250
R01 · FY2015 · HL · contact PI
Role of Neuropilin receptors in lymphangiogenesis$410,006
R01 · FY2015 · HL · contact PI
Novel approaches to manipulate sprouting angiogenesis$374,625
R01 · FY2015 · EY · contact PI
Role of Neuropilin receptors in lymphangiogenesis$407,925
R01 · FY2014 · HL · contact PI
Role of Neuropilin receptors in lymphangiogenesis$395,576
R01 · FY2013 · HL · contact PI
Role of Neuropilin receptors in lymphangiogenesis$414,271
R01 · FY2012 · HL · contact PI